MedTrace Logo

DTM (TM) Spinal Cord Stimulation (SCS) Study

NCT04601454 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2023-02-24

Study results available
· View outcomes & findings →

Summary

Prospective, multi-center, open-label, post-market study to evaluate the efficacy and energy use of a low energy DTM™ (DTM-LE) SCS therapy for pain relief.

Conditions

Interventions

DEVICE

Spinal Cord Stimulation System

Rechargeable Implanted neurostimulation system (neurostimulator and leads) with on-label stimulation parameters.

Sponsors & Collaborators

  • MedtronicNeuro

    lead INDUSTRY

Principal Investigators

  • Restorative Therapies Group Restorative Therapies Group · Medtronic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-05
Primary Completion
2021-11-29
Completion
2022-08-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04601454 on ClinicalTrials.gov